Abstract
The first PROTAC degrader of ASK1, dASK1-VHL (60), was rationally designed and validated via in vitro assays and PK studies, demonstrating therapeutic efficacy in an MCD diet-induced MASH mouse model, underscoring its promise in metabolic diseases.
Funding Information
  • Council of Scientific and Industrial Research, India (FTT070504)

This publication has 60 references indexed in Scilit: